GlassScriptPhysician profile
Kaitlyn Tucker
NPI 1164068805
$737.48
in general payments reported to CMS, 2019-2025
12 companies · $391 in 2025
The $391 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $66.24 · 2022: $53.42 · 2023: $95.23 · 2024: $132 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $168.64 | 2023-2025 | Gemtesa |
| Janssen Biotech, INC. | $147.71 | 2025 | Rybrevant, Carvykti, Erleada |
| Novo Nordisk INC | $119.66 | 2021-2022 | |
| Pfizer INC. | $64.43 | 2023-2025 | |
| Olympus America INC. | $55.63 | 2025 | Itind System |
| Recordati_rare_diseases_inc. | $42.94 | 2025 | Isturisa |
| Astellas Pharma US INC | $42.65 | 2024 | Myrbetriq |
| Procept Biorobotics Corporation | $23.98 | 2025 | |
| Urogen Pharma, INC. | $20.27 | 2025 | |
| Profound Medical Corp. | $19.60 | 2025 | Tulsa-Pro |
| Teleflex LLC | $16.48 | 2024 | Urolift |
| Medtronic, INC. | $15.49 | 2025 | Interstim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlyn Tucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.